期刊文献+

经典Wnt/β-catenin/TCF7L2信号通路在1型糖尿病心肌病中的作用 被引量:11

Effect of activated canonical Wnt/β-catenin/TCF7L2 signaling pathway in type 1 diabetic cardiomyopathy
下载PDF
导出
摘要 目的 探讨Wnt/β-catenin/TCF7L2信号通路在1型糖尿病小鼠心肌病中的作用。方法利用7~8周龄♂C57BL/6小鼠腹腔注射链脲佐菌素,建立1型糖尿病模型,糖尿病小鼠成模4周后,随机分为糖尿病组、β-catenin通路抑制剂iCRT14(2.5、5 mg·kg^-1)组。连续腹腔给药8周后,HE染色检测心脏细胞形态;免疫组化及Western blot检测β-catenin、TCF7L2蛋白表达;荧光定量PCR检测β-catenin、Tcf7l2、Nppa、c-Myc mRNA表达。结果糖尿病组心肌细胞排列相对紊乱、细胞核大小不规则;Western blot和免疫组化结果显示,糖尿病组小鼠心脏β-catenin、TCF7L2表达升高,心肌细胞核内β-catenin、TCF7L2表达明显增多;qPCR显示,β-catenin/TCF7L2通路下游基因c-Myc、心肌肥大基因Nppa表达上调。iCRT14组小鼠心肌细胞排列相对规则,形态趋于正常;β-catenin、TCF7L2蛋白表达降低,核内表达减少;肥大基因Nppa、下游基因c-Myc mRNA表达明显减低。结论 Wnt/β-catenin/TCF7L2通路活化在糖尿病心肌病发生、发展中发挥重要作用,β-catenin抑制剂能明显减缓1型糖尿病小鼠心肌病的进程。 Aim To determine the role of Wnt/β-catenin/TCF7L2 pathway in diabetic cardiomyopathy.Methods A model of type 1 diabetes mellitus was established by intraperitoneal injection of streptozotocin(STZ) into 7 or 8-week old C57BL/6 mice.After four weeks,the diabetic animals were divided into three groups with seven to eight in each:diabetes mellitus(DM),diabetes injected with β-catenin inhibitor iCRT14(2.5,5 mg·kg^-1).After continuous intrap- eritoneal administration for 8 weeks,heart samples were stained with HE and examined under light microscopy.Expressions and distributions of β-catenin and TCF7L2 in myocardium were detected by immunohistochemistry.Protein levels of β-catenin,Tcf7l2 were detected by Western blot.mRNA levels of β-catenin,Tcf7l2,Nppa and c-Myc were detected by qPCR.Results The myocardial cells in DM were relatively disordered and the size of the nucleus was irregular.Western blot and immunohistochemistry data showed that the expressions of β-catenin and TCF7L2 in heart with DM increased,while those in nucleus of the cardiomyocytes significantly increased.qPCR showed that the mRNA expression of β-catenin downstream target c-Myc and cardiac hypertrophy marker Nppa were up-regulated.After injection of eight weeks with different iCRT14 doses,the cardiomyocytes were relatively regular;the protein levels of β-catenin and TCF7L2 decreased,and their expressions in nucleus decreased as well;the mRNA levels of Nppa and c-Myc markedly decreased.Conclusions Activation of canonical Wnt/β-catenin/TCF7L2 signaling pathway plays a pivotal role in diabetic cardiomyopathy;iCRT14 significantly improves the phenotype of cardiomyopathy in type 1 diabetic mice.
作者 邱晓霞 李逸朗 梁关凤 张贵平 罗健东 袁文常 侯宁 QIU Xiao-xia;LI Yi-lang;LIANG Guan-feng;ZHANG Gui-ping;LUO Jian-dong;YUAN Wen-chang;HOU Ning(Dept of Pharmacology,Guangzhou Medical University,Guangzhou 511436,China;Dept of Clinical Lab,the Fifth Affiliated Hospital of Guangzhou Medical University,Guangzhou 510000,China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2019年第8期1104-1109,共6页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81773720,81402928) 广州市科技计划项目(No 201804010490) 广州市教育科研计划项目(No 1201610064)
关键词 糖尿病 链脲佐菌素 心肌肥厚 Wnt/β-catenin/TCF7L2信号通路 iCRT14 c-Myc Nppa diabetes streptozotocin cardiac hypertrophy Wnt/β-catenin/TCF7L2 signaling pathway iCRT14 c-Myc Nppa
  • 相关文献

参考文献2

二级参考文献28

  • 1COHEN M.Use of lispro insulin in pregnancy:a 2 year experience[J].Diabetes,1999,48(Suppl):A 468.
  • 2RAYMN G,SONHAMI E.Insulisime provides superior postprandial glucose control with less noctural hypoglycaemia compared with regular human insulin in subjects with type 2 diabetes[J].Diabetologia,2005,48(Suppl17):A4.
  • 3SCHOLTZ H E,PRETORUS S G,WESSELS D H,et al.Pharmacokinetic and glucodynamic variability:assessment of insulin glargine,NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique[J].Diabetologia,2005,48:1988-1995.
  • 4SCHEEN A J,RADERMECKER R P,PHILIPS J C,et al.Insulin detemir (Levemir)[J].Rev Med Liege,2005,60:814-819.
  • 5KURTZHALS P.Engineering predictability and protraction in a basal insulin analogue:the pharmacology of insulin detemir[J].Int J Obes Relat Metab Disord,2004,28(Suppl 2):S23-28.
  • 6FRITSCHE A,HARING H.At last,a weight neutral insulin?[J].Int J Obes Relat Metab Disord,2004,28(Suppl)2:S41-46.
  • 7SHOJAEE-MORADIE F,POWRIE J K,SUNDERMANN E,et al.Novel hepatoselective insulin analog:studies with a covalently linked thyroxyl-insulin complex in humans[J].Diabetes Care,2000,23:1124-1129.
  • 8SHOJAEE-MORADIE F,CHAN M P,TELFER M A,et al.Effect of thyroid hormone binding proteins on insulin receptor binding of B1-thyronine-insulin analogues[J].Biochem J,2004,381:51-57.
  • 9SCHMITZ O,NYHOLM B,JUHL C B,et al.Aspects of secretion and actions of amylin:interplay between amylin and other hormones[J].J Endocrinol Invest,1999,22(Suppl):S33-36.
  • 10WHIEHOUSE F,KRUGER D F.A randomised study and open-label extension the long-term efficacy of pralintide as an adjunct to insulin therapy in type 1 diabetes[J].Diabetes Care,2002,25:724-730.

共引文献11

同被引文献60

引证文献11

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部